During the past decade, Polyclinique De Courlancy conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique De Courlancy" #1 sponsor was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 20 trials, followed by "UNICANCER" with 5 trials sponsored, "Centre Oscar Lambret" with 3 trials sponsored, "Institut de Cancérologie de Lorraine" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique De Courlancy" #1 collaborator was "AlpinARC" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "CRG : Groupe Francophone de Chirurgie Robotique en Gynécologie" with 1 trials as a collaborator and "Coloplast A/S" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique De Courlancy" are "Colorectal Cancer" (8 trials), "Breast Cancer" (7 trials), "Lung Cancer" (5 trials), "Pancreatic Cancer" (5 trials) and "Ovarian Cancer" (3 trials). Many other conditions were trialed in "Polyclinique De Courlancy" in a lesser frequency.

Most popular intervention types in "Polyclinique De Courlancy" are "Drug" (37 trials), "Procedure" (12 trials), "Radiation" (8 trials), "Genetic" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (10 trials), "oxaliplatin" (9 trials), "gemcitabine hydrochloride" (8 trials), "leucovorin calcium" (7 trials) and "radiation therapy" (7 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique De Courlancy" are 33 trials for "All" genders, 13 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Polyclinique De Courlancy". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Polyclinique De Courlancy, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique De Courlancy, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".